SWTX — SpringWorks Therapeutics Share News
0.000.00%
Last trade - 00:00- $3.54bn
- $3.25bn
- $191.59m
U.S. RESEARCH ROUNDUP-Bark, Fleetcor Technologies, Tesla
Brief: SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA
Brief: SpringWorks Therapeutics FY basic EPS USD -5.15
SpringWorks Therapeutics Inc expected to post a loss of $1.24 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Burlington Stores, Carrols Restaurant Group, Mastec
U.S. STOCKS ON THE MOVE-Enphase, Evolent Health, Procter & Gamble
U.S. STOCKS ON THE MOVE-G-III Apparel, AutoZone, Apple
Brief: Mckesson Biologics By Mckesson Was Selected By Springworks Therapeutics As A Limited Distribution Specialty Pharmacy For Ogsiveo (Nirogacestat)
U.S. STOCKS ON THE MOVE-CVS, JM Smucker, Fedex
SpringWorks Therapeutics falls on pricing $275 mln stock offering
Brief: Springworks Therapeutics Announces Pricing Of Upsized Public Offering Of Common Stock
Brief: Springworks Therapeutics Announces Proposed Public Offering Of Common Stock
U.S. RESEARCH ROUNDUP-Argenx SE, Avalonbay Communities, Cooper Companies
U.S. STOCKS ON THE MOVE-Crocs, Avidity Biosciences, oil companies
U.S. STOCKS ON THE MOVE-Taboola, Cool Company, Twilio
SpringWorks gains after FDA approves non-cancerous tumor treatment for adults
U.S. STOCKS ON THE MOVE-Gold miners, Estee Lauder, Adobe
SpringWorks' non-cancerous tumor drug to be priced at $29,000 per month in US (updated)
SpringWorks non-cancerous tumor drug to be priced at $29,000 per month in US